Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;2(1):e6-e7.
doi: 10.1016/S2666-7568(20)30047-7. Epub 2020 Dec 3.

Metformin: an inexpensive and effective treatment in people with diabetes and COVID-19?

Angela Dardano  1 , Stefano Del Prato  1
Affiliations
Comment

Metformin: an inexpensive and effective treatment in people with diabetes and COVID-19?

Angela Dardano et al. Lancet Healthy Longev. 2021 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782–792. - PMC - PubMed
    1. Coppelli A, Giannarelli R, Aragona M, et al. Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study. Diabetes Care. 2020;43:2345–2348. - PubMed
    1. Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31:1068–1077. - PMC - PubMed
    1. Bramante CT, Ingraham NE, Murray TA, et al. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. Lancet Healthy Longev. published online Dec 3. - DOI - PMC - PubMed
    1. Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020;43:1399–1407. - PubMed